Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 55
- +6 vs. Q2 2021
- Portfolio value
- $303.3M
- −$16.5M (−5.2%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRVBProvention Bio, Inc. | COM | 50,000 | $320.0K | 0.1% | −50,000−50.0% | Reduced | History |
| TBIOTelesis Bio Inc. | COM | 35,000 | $390.0K | 0.1% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 2,000 | $546.0K | 0.2% | +2,000 | New | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $774.0K | 0.3% | 00.0% | Unchanged | History |
| OTICOtonomy, Inc. | COM | 450,000 | $864.0K | 0.3% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 100,000 | $1.22M | 0.4% | +100,000 | New | History |
| CMRXChimerix Inc | COM | 200,000 | $1.24M | 0.4% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 50,000 | $1.41M | 0.5% | +50,000 | New | History |
| MRUSMerus N.V. | COM | 75,000 | $1.65M | 0.5% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 80,000 | $1.83M | 0.6% | +80,000 | New | History |
| MRNAModerna, Inc. | Stock | 5,300 | $2.04M | 0.7% | +1,300+32.5% | Added | History |
| LRMRLarimar Therapeutics, Inc. | COM | 200,000 | $2.31M | 0.8% | +100,000+100.0% | Added | History |
| IMUXImmunic, Inc. | COM | 265,000 | $2.35M | 0.8% | 00.0% | Unchanged | History |
| Bellus Health Inc New07987C204 | COM NEW | 400,000 | $2.46M | 0.8% | +400,000 | New | – |
| FOLDAmicus Therapeutics, Inc. | COM | 265,000 | $2.53M | 0.8% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 75,000 | $2.88M | 0.9% | −50,000−40.0% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 50,000 | $2.96M | 1.0% | −135,000−73.0% | Reduced | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 100,000 | $2.99M | 1.0% | +100,000 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 150,000 | $3.16M | 1.0% | −93,309−38.3% | Reduced | History |
| NMTR9 Meters Biopharma, Inc. | COM | 2,750,000 | $3.58M | 1.2% | +2,750,000 | New | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $3.66M | 1.2% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 150,000 | $3.85M | 1.3% | −125,000−45.5% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 160,000 | $4.06M | 1.3% | +15,000+10.3% | Added | History |
| TCRRTCR2 Therapeutics Inc. | COM | 477,323 | $4.06M | 1.3% | +477,323 | New | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $4.11M | 1.4% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 750,000 | $4.11M | 1.4% | −250,000−25.0% | Reduced | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 100,000 | $4.16M | 1.4% | −100,000−50.0% | Reduced | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $4.21M | 1.4% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 65,000 | $4.33M | 1.4% | +65,000 | New | History |
| SRRASierra Oncology, Inc. | COM NEW | 200,000 | $4.38M | 1.4% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 250,000 | $4.62M | 1.5% | +250,000 | New | History |
| CTICCti Biopharma Corp | COM | 1,600,000 | $4.72M | 1.6% | 00.0% | Unchanged | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $4.94M | 1.6% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 275,000 | $4.95M | 1.6% | +25,000+10.0% | Added | History |
| RLMDRelmada Therapeutics, Inc. | COM | 200,000 | $5.24M | 1.7% | +200,000 | New | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 150,000 | $5.26M | 1.7% | +150,000 | New | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $5.48M | 1.8% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 350,000 | $5.76M | 1.9% | 00.0% | Unchanged | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 700,000 | $6.15M | 2.0% | +100,000+16.7% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 200,000 | $6.59M | 2.2% | +200,000 | New | History |
| CYPHCypherpunk Technologies Inc. | COM | 1,650,000 | $6.62M | 2.2% | +1,650,000 | New | History |
| RAPTRAPT Therapeutics, Inc. | COM | 250,000 | $7.76M | 2.6% | −320,000−56.1% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 425,000 | $7.96M | 2.6% | −275,000−39.3% | Reduced | History |
| GHRSGH Research PLC | ORDINARY SHARES | 400,000 | $8.82M | 2.9% | +400,000 | New | History |
| ALLKAllakos Inc. | COM | 85,000 | $9.00M | 3.0% | +85,000 | New | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 350,000 | $10.5M | 3.4% | +225,000+180.0% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 60,000 | $10.6M | 3.5% | +10,000+20.0% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 575,000 | $11.0M | 3.6% | −300,000−34.3% | Reduced | History |
| ISEEIVERIC bio, Inc. | COM | 725,000 | $11.8M | 3.9% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 790,000 | $12.1M | 4.0% | −60,000−7.1% | Reduced | History |
| ARVNArvinas, Inc. | COM | 150,000 | $12.3M | 4.1% | −55,000−26.8% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 1,500,000 | $12.6M | 4.2% | −100,000−6.3% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 255,000 | $13.8M | 4.5% | −30,000−10.5% | Reduced | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 700,000 | $17.3M | 5.7% | +250,000+55.6% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 120,000 | $19.1M | 6.3% | −15,000−11.1% | Reduced | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q2 2021 (10)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| Trillium Therapeutics Inc.89620X506 | COM NEW | 1,250,000 | $12.1M | 3.8% | – |
| BIIBBiogen Inc. | COM | 32,500 | $11.3M | 3.5% | History |
| TGTXTG Therapeutics, Inc. | COM | 180,000 | $6.98M | 2.2% | History |
| MRSNMersana Therapeutics, Inc. | COM | 450,000 | $6.11M | 1.9% | History |
| EPIXESSA Pharma Inc. | COM NEW | 207,500 | $5.93M | 1.9% | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 75,000 | $5.17M | 1.6% | History |
| KDMNKadmon Holdings, Inc. | COM | 800,000 | $3.10M | 1.0% | History |
| CRISCuris Inc | COM NEW | 247,124 | $1.99M | 0.6% | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 75,000 | $1.92M | 0.6% | History |
| ELEVElevation Acquisition Group Inc. | COM | 100,000 | $1.36M | 0.4% | History |